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During immune responses, B cells diversify 
their Ig genes by somatic hypermutation (SHM) 
and class switch recombination (CSR). SHM 
modifies  antibody  affinities  by  introducing   
mutations in the variable region of heavy (IgH) 
and light chain genes (Di Noia and Neuberger, 
2007). CSR modulates antibody effector func-
tions by replacing the antibody isotype ex-
pressed through a DNA recombination reaction 
that joins two switch regions (Chaudhuri et al., 
2007). SHM and CSR are initiated by the de-
amination of cytosines to uracils in single-
stranded DNA mediated by activation-induced 
cytidine deaminase (AID; Petersen-Mahrt et al., 
2002;  Chaudhuri  et  al.,  2007;  Di  Noia  and 
Neuberger, 2007). The resulting dU:dG mis-
matches are differentially processed to generate 
mutations in variable regions during SHM or 
double-stranded DNA breaks (DSBs) in switch 
regions during CSR (Chaudhuri et al., 2007; 
Di Noia and Neuberger, 2007). AID appears to 
find its targets by its binding to Spt5 and RNA 
polymerase II (Pavri et al., 2010) and distin-
guishes between variable and switch regions by 
its  association  with  proteins  like  RPA,  PKA, 
14-3-3, or by the formation of higher-order 
DNA structures in switch regions (Chaudhuri 
et al., 2007; Vuong et al., 2009; Xu et al., 2010; 
Yamane et al., 2011). AID itself also contributes 
to  this  choice,  as  N-terminal  mutations  in 
AID result in normal CSR but defective SHM 
(Shinkura et al., 2004; Wei et al., 2011) and con-
versely C-terminal truncations in AID result in 
normal SHM but defective CSR (Chaudhuri 
et al., 2007; Kracker et al., 2010). The latter 
phenotype is also observed in mice deficient 
for DNA damage response (DDR) components 
(Ramiro et al., 2007) and in a subset of hyper IgM 
patients with a CSR-specific defect (Kracker 
et al., 2010). It has been proposed that this 
domain  associates  with  CSR-specific  factors 
that  could  be  required  for  targeting AID  to 
switch regions (Ta et al., 2003) or for recombi-
nation downstream of DSB formation either by 
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Immunoglobulin class switch recombination (CSR) is initiated by double-stranded DNA breaks 
(DSBs) in switch regions triggered by activation-induced cytidine deaminase (AID). Although 
CSR correlates with epigenetic modifications at the IgH locus, the relationship between these 
modifications and AID remains unknown. In this study, we show that during CSR, AID forms a 
complex with KAP1 (KRAB domain–associated protein 1) and HP1 (heterochromatin protein 1) 
that is tethered to the donor switch region (S) bearing H3K9me3 (trimethylated histone H3 at 
lysine 9) in vivo. Furthermore, in vivo disruption of this complex results in impaired AID recruit-
ment to S, inefficient DSB formation, and a concomitant defect in CSR but not in somatic 
hypermutation. We propose that KAP1 and HP1 tether AID to H3K9me3 residues at the donor 
switch region, thus providing a mechanism linking AID to epigenetic modifications during CSR.
©  2011  Jeevan-Raj  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
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lower than AIDFlag-HA or EGFPFlag-HA (Fig. S1), we found that 
C-terminal deletion in AID did not disrupt its association 
with KAP1 (Fig. 1 C). To determine whether the association 
between AID and KAP1 can take place within chromatin, we 
performed a coimmunoprecipitation experiment on chroma-
tin fractions prepared from CH12 B cells expressing tagged 
AIDFlag-HA. We found that chromatin-bound AID reciprocally 
coimmunoprecipitated with KAP1 (Fig. 1 D). We conclude 
that endogenous KAP1 associates with nuclear and chromatin-
bound tagged AID through interactions that do not require 
its C-terminal domain.
KAP1 is required for efficient CSR but is dispensable for SHM
To determine whether KAP1 plays a role in CSR and SHM, 
we bred Kap1 floxed mice (Kap1F/F; Cammas et al., 2000) 
with CD19Cre/+ transgenic mice (Rickert et al., 1997) to in-
activate Kap1 in developing B cells. Despite efficient Cre-
mediated deletion, no differences were observed in cellularity 
in the bone marrow or the spleen (not depicted), and B cell 
development appeared to be unaffected (Fig. S2). To deter-
mine whether CSR is affected by Kap1 deficiency, we cul-
tured  in  vitro  CFSE-labeled  splenic  B  cells  isolated  from 
CD19Cre/+Kap1F/F and control mice under conditions that 
induce CSR to various isotypes. We found that Kap1 defi-
ciency had no effect on proliferation (Fig. 2 A) or survival 
(not depicted). However, Kap1 deficiency resulted in a 40–
50% reduction in CSR to all isotypes tested (Fig. 2, A–C). 
Consistent with this, the level of postrecombination I-CH 
transcripts, which appear only after recombination, was sig-
nificantly reduced in CD19Cre/+Kap1F/F B cells (Fig. 2 C and 
Fig. S3). We conclude that Kap1 deficiency results in a   
B cell–intrinsic defect in CSR that is independent of abnormali-
ties in survival or proliferation.
To determine whether SHM is also affected by Kap1 de-
ficiency, we immunized CD19Cre/+Kap1F/F and control mice 
with NP-CGG, sorted germinal center B cells from the 
lymph nodes, and analyzed JH4 intron sequences for muta-
tions (Jolly et al., 1997). We did not find significant differ-
ences in mutation frequency (Fig. 2 D; P = 0.12), distribution, 
or  pattern  (Fig.  S4)  between  sequences  obtained  from 
CD19Cre/+Kap1F/F (n = 83) and control (n = 91) animals. We 
conclude that KAP1 is involved in mediating CSR but ap-
pears to be dispensable for SHM.
mediating  RNA  editing  (Doi  et  al.,  2009;  Nonaka  et  al., 
2009) or by recruiting factors that promote efficient DNA 
repair (Barreto et al., 2003; Ta et al., 2003; Ito et al., 2004; 
Shinkura et al., 2004; Kracker et al., 2010). In addition, epi-
genetic modifications at the IgH locus, including histone H3 
trimethylation at lysine 9 (H3K9me3), have been suggested to 
target the CSR machinery to switch regions (Wang et al., 
2006, 2009; Chowdhury et al., 2008; Kuang et al., 2009). 
However, a direct causal link between these modifications 
and AID function in CSR has not been established.
RESULTS
AID associates with KAP1 (KRAB domain–associated protein 1)
To identify nuclear proteins associating with AID, we per-
formed  sequential  immunoprecipitations  followed  by  mass 
spectrometry identification using nuclear extracts prepared 
from CH12 B cells expressing tagged AID (AIDFlag-HA; Fig. S1). 
As negative controls, we used cell lines expressing the tags 
alone (Flag-HA) or an irrelevant tagged protein (EGFPFlag-HA). 
Among  the  identified  proteins  specifically  coprecipitating 
with AID but not with the negative controls, we found known 
AID partners, DNA-PKCS (Wu et al., 2005) and CRM1 (Brar 
et al., 2004; Ito et al., 2004; McBride et al., 2004; Geisberger 
et al., 2009), proteins previously implicated in CSR, Ikaros 
(Sellars et al., 2009), MSH2 (Chaudhuri et al., 2007), and 
MSH6 (Chaudhuri et al., 2007), and proteins with no known 
function in SHM or CSR, like KAP1 (Fig. S1). KAP1 (also 
known as TRIM28, KRIP1, or Tif1) was selected for analy-
sis because it has been previously implicated as an effector of 
the DDR (Ziv et al., 2006). KAP1 is also a transcriptional co-
repressor (Cammas et al., 2000) that associates with members 
of the HP1 (heterochromatin protein 1) family to participate 
in chromatin packaging and heterochromatin formation 
(Nielsen et al., 1999). The association between AID and KAP1 
was confirmed by reciprocal immunoprecipitations and West-
ern blotting (Fig. 1 A) and was specific, as KAP1 did not co-
precipitate  with  EGFPFlag-HA  (Fig.  1  B),  despite  relatively 
higher  expression  of  EGFPFlag-HA  (Fig.  S1). To  determine 
whether AID associates with KAP1 through its C terminus, 
we performed immunoprecipitation and Western blot experi-
ments using extracts prepared from CH12 cells expressing   
an AID C-terminal truncation mutant (AIDFlag-HA 182–198).   
Although the expression level of AIDFlag-HA 182–198 is significantly 
Figure 1.  KAP1 associates with AID. (A–C) Nuclear extracts prepared from CH12 cells stably expressing AIDFlag-HA (A), EGFPFlag-HA (B), or AIDFlag-HA 182–198 
(C) were immunoprecipitated and blotted with anti-KAP1 and anti-Flag antibodies. Because of the lower expression levels of AIDFlag-HA 182–198 when  
compared with AIDFlag-HA or EGFPFlag-HA (Fig. S1), loading for Western blot (WB) analysis was adjusted accordingly in C. (D) Chromatin fractions prepared 
from CH12 cells expressing AIDFlag-HA were immunoprecipitated and blotted with anti-KAP1 and anti-Flag antibodies. Input control represents 1% of ma-
terial used for immunoprecipitation (IP). Molecular mass markers in kilodaltons are indicated. Data are representative of five independent experiments.JEM Vol. 208, No. 8 
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The function of KAP1 in CSR is upstream of DSB resolution
CSR is dependent on transcription (Chaudhuri et al., 2007), 
and KAP1 is a transcriptional corepressor (Cammas et al., 
2000). To determine whether switch region transcription is 
affected by Kap1 deficiency, we measured by quantitative 
RT-PCR (qRT-PCR) the level of switch region germline tran-
scripts in activated B cells. We found no significant reduction 
in the level of these transcripts in Kap1-deficient B cells (Fig. 3 A 
and Fig. S3). However, occasional increases in the levels of 3, 
1, 2b, and 2a transcripts were found (Fig. 3 A and Fig. S3). 
This is similar to what is observed in Atm/, H2ax/, or 
53bp1/ B cells in which CSR is reduced despite normal or 
increased levels of switch region transcripts (Reina-San-Martin 
et al., 2003, 2004; Ward et al., 2004). We conclude that 
switch regions continue to be efficiently transcribed in Kap1- 
deficient B cells and that switch regions are accessible for 
DNA deamination by AID. Therefore, the function of KAP1 
is downstream of switch region transcription.
To determine whether Kap1 deficiency affects AID ex-
pression, we measured the level of AID protein in activated 
B cells by Western blot. For comparison, we used AID-deficient 
(AIDCre/Cre) B cells, which were obtained from mice bearing 
a targeted insertion of the CRE recombinase cDNA into 
AID’s exon 1 (Robbiani et al., 2008) and which displayed the 
same phenotype as AID/ mice (Muramatsu et al., 2000). 
Reduced levels in AID protein were found in AIDCre/+  
B cells (Fig. 3 B), as has been reported for AID+/ B cells 
(Sernández et al., 2008). In contrast, Kap1 deficiency had no 
deleterious effect on AID protein levels (Fig. 3 B). Consistent 
with  this,  retroviral  overexpression  of  full-length  AID  in 
Kap1-deficient B cells did not rescue CSR, whereas it did in 
AID-deficient B cells (Fig. S5). As expected, overexpression 
of C-terminal truncation AID mutants had no effect on CSR 
in either AID- or in Kap1-deficient B cells (Fig. S5). We 
conclude that defective CSR in Kap1-deficient B cells is not 
caused by reduced levels of AID and that KAP1 functions 
downstream of AID expression.
KAP1 is phosphorylated at serine 824 (-KAP1) by the 
ATM kinase and accumulates in -H2AX–containing foci   
in response to DNA damage (Ziv et al., 2006). Furthermore, 
inactivation of DDR components (i.e., ATM and H2AX) 
results in defective CSR (Ramiro et al., 2007). To determine 
whether KAP1 is phosphorylated during CSR, we assayed 
for -KAP1 by Western blot. KAP1 phosphorylation was 
readily detected in control cells exposed to the DSB-inducing 
chemical neocarzinostatin (Fig. 3 C). Despite robust levels   
Figure 2.  KAP1 is required for efficient CSR but is dispensable for 
SHM. (A) IgG1 surface expression and CFSE dilution by flow cytometry in 
CD19Cre/+, Kap1F/F, CD19Cre/+Kap1F/+, and CD19Cre/+Kap1F/F B cells stimulated 
with LPS + IL-4 for 72 h. The percentage of switched cells is indicated in 
each plot. (B) Percentage (+SD) of CSR after 72 h in CD19Cre/+Kap1F/F rela-
tive to CD19Cre/+Kap1F/+ for the different isotypes tested (CSR to IgA and 
IgE could not be determined). CSR in CD19Cre/+Kap1F/+ B cells was set to 
100%. Data are from five independent experiments. (C) qRT-PCR for post-
switch (I-CH) transcripts in CD19Cre/+Kap1F/F relative to CD19Cre/+Kap1F/+ 
stimulated B cells (72 h). Expression is normalized to Cd79b expression and 
is presented relative to the expression in CD19Cre/+Kap1F/+ B cells, set as 1. 
Data are representative of three experiments. Error bars indicate SD. (D) JH4 
intron sequences from germinal center B cells (B220+Fas+GL-7+) sorted 
from the lymph nodes of immunized CD19Cre/+Kap1F/F and CD19Cre/+Kap1F/+ 
mice were analyzed for mutations. Segment sizes are proportional to the 
number of sequences bearing the indicated mutations. Mutation frequency 
(mutations/base pair [m/bp]) and number of sequences analyzed (in center) 
are indicated. Sequences were obtained from four independent experi-
ments. (B–D) P-values were determined by the Student’s t test.
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Sequence analysis revealed no significant differences (P = 
0.9175) in the amount of microhomology at the junctions 
between groups (Fig. 3 E). We conclude that CSR junctions 
are unaffected by Kap1 deficiency and that DNA ends are re-
paired normally by NHEJ.
Inactivation of core NHEJ or DDR components results 
in global and IgH-specific genomic instability (Franco et al., 
2006;  Yan et al., 2007). To determine whether Kap1 deficiency 
results in the accumulation of unresolved DNA breaks trig-
gered by AID in switch regions, we performed two-color 
IgH-specific fluorescence in situ hybridization (IgH-FISH; 
Franco et al., 2006; Yan et al., 2007) on metaphase spreads 
prepared from CD19Cre/+Kap1F/F (n = 593) and control   
(n = 780) activated B cells. Contrary to Atm/ or Xrcc4/ B cells 
of AID expression, -KAP1 was not detected in activated   
B cells (Fig. 3 C), indicating that KAP1 phosphorylation, if any, 
is below detection threshold. To determine whether a small 
fraction of KAP1 is phosphorylated during CSR, we immuno-
precipitated -KAP1 and blotted for KAP1 (Fig. 3 D). Although 
-KAP1  was  detected  under  these  conditions,  KAP1  phos-
phorylation was not dependent on AID expression (Fig. 3 D). 
We conclude that the role of KAP1 in CSR is independent 
of its phosphorylation status at serine 824.
CSR requires the generation of DSBs in switch regions 
and their resolution by nonhomologous end joining (NHEJ; 
Yan et al., 2007). To determine whether CSR junctions are 
affected by Kap1 deficiency, we compared IgG3 CSR junctions 
from CD19Cre/+Kap1F/F (n = 52) and control (n = 46) B cells. 
Figure 3.  KAP1 functions downstream of switch region transcription and upstream of DSB formation. (A) qRT-PCR for germline (IH-CH) tran-
scripts in CD19Cre/+Kap1F/F relative to CD19Cre/+Kap1F/+ stimulated B cells (72 h). Expression is normalized to Cd79b and relative to CD19Cre/+Kap1F/+ B cells, 
set as 1. P-values were determined by the Student’s t test. Data are from three independent experiments. Error bars indicate SD. (B) Western blot for AID 
and -actin in Kap1F/F, CD19Cre/+Kap1F/+, CD19Cre/+Kap1F/F, AID+/+, AIDCre/+, and AID-deficient (AIDCre/Cre) B cells. Numbers below the panel reflect the inten-
sity of bands representing AID protein levels relative to controls after normalization to -actin. Molecular mass markers in kilodaltons are indicated. Data 
are representative of three independent experiments. (C) KAP1 phosphorylation (-KAP1) by Western blot in wild-type B cells cultured with LPS + IL-4. As 
a positive control, CH12 cells treated with neocarzinostatin (NCS). (D) -KAP1 was immunoprecipitated from activated AID+/+ and AID-deficient (AIDCre/Cre) 
B cells and blotted for KAP1. Data are representative of two independent experiments. IP, immunoprecipitation; WB, Western blot. (E) Percentage of S/S3  
switch junction sequences with indicated nucleotide overlap from CD19Cre/+Kap1F/+ and CD19Cre/+Kap1F/F LPS-stimulated B cells (72 h) from five indepen-
dent experiments. Mean length of overlap in base pairs and the number of sequences analyzed (n) is indicated. (F) Quantification of IgH locus breaks as 
determined by IgH-FISH on metaphases prepared from control (n = 780) and CD19Cre/+Kap1F/F (n = 593) B cells cultured for 3 d with anti-CD40 and IL-4. 
Mean (+SEM) is shown. Data are from two independent experiments (Table S1). (E and F) P-values were determined by the Mann-Whitney test.  
(G) Frequency of IgH/c-myc translocations in CD19Cre/+Kap1F/F and CD19Cre/+Kap1F/+ B cells determined by long-range PCR and Southern blot in three inde-
pendent experiments. The p-value was determined by the one-tailed exact Fisher’s test.JEM Vol. 208, No. 8 
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the level of AID-induced DNA damage in switch regions 
(Barreto et al., 2003; Guikema et al., 2007). We found that the 
proportion of mutated sequences and the mutation frequency 
were reduced (P = 0.040) in CD19Cre/+Kap1F/F (F = 0.78 × 
103 mutations/bp; n = 170) when compared with controls 
(F = 1.07 × 103 mutations/bp; n = 169; Fig. 4 B). A signifi-
cant reduction (P = 1.5 × 1019) in mutation frequency in 
the 5 end of S was also found in Kap1-deficient B cells 
when sequences were analyzed in a larger dataset by high-
throughput amplicon sequencing (HTS; Fig. 4 C). We con-
clude that impaired AID recruitment to S results in reduced 
levels of DNA damage and consequently in defective CSR.
AID forms a complex with KAP1 and HP1  
that binds H3K9me3
Epigenetic modifications at the IgH locus have been suggested 
to target the CSR machinery to switch regions by relaxing 
chromatin or by providing binding motifs for factors involved in 
CSR (Odegard et al., 2005; Wang et al., 2006; Fraenkel et al., 
2007; Chowdhury et al., 2008; Kuang et al., 2009; Wang et al., 
2009). Among these, H3K9me3, which is usually associated 
with silent genes and heterochromatin, was found at transcribed 
donor and acceptor switch regions (Chowdhury et al., 2008; 
Kuang et al., 2009). We hypothesized that AID could be tethered 
to transcribed switch regions bearing this modification through 
the association between AID, KAP1, and HP1 and the ability of 
the latter to bind H3K9me3 (Bannister et al., 2001). To deter-
mine whether AID also associates with HP1, we performed 
reciprocal coimmunoprecipitation experiments using nuclear 
extracts prepared from cells expressing AIDFlag-HA and antibodies 
specific for the different HP1 isoforms. Although AIDFlag-HA  
coprecipitated with all HP1 isoforms, only HP1- reciprocally 
(Yan et al., 2007), we found no significant increase (P = 0.9) 
in the percentage of metaphases with abnormalities in Kap1-
deficient B cells (Fig. 3 F and Table S1). Consistent with this, 
we found that Kap1 disruption did not result in increased fre-
quency of AID-dependent IgH/c-myc translocations (Fig. 3 G). 
We conclude that in the absence of KAP1, DSBs generated at 
switch regions are efficiently repaired and do not lead to global 
or IgH-specific genomic instability. Therefore, KAP1 functions 
upstream of the AID-induced DNA breaks that initiate CSR.
AID binding to S is impaired by Kap1 deficiency
To determine whether AID recruitment to the S switch re-
gion is dependent on KAP1, we performed chromatin immuno-
precipitation (ChIP) analysis using an anti-AID antibody (Pavri 
et al., 2010) on chromatin prepared from CD19Cre/+Kap1F/+, 
CD19Cre/+Kap1F/F, and AIDCre/Cre activated B cells (Fig. 4 A). 
We found that AID occupancy at the S switch region was 
significantly reduced (P < 0.0001) in CD19Cre/+Kap1F/F when 
compared with CD19Cre/+Kap1F/+ B cells (Fig. 4 A). AID-ChIP 
signal in CD19Cre/+Kap1F/F B cells relative to controls ranged 
between 20 and 50% (depending on the experiment; not de-
picted) and was specific, as only background levels of immuno-
precipitated AID protein were observed at S in AIDCre/Cre  
B cells. We conclude that AID binding to the donor switch   
region is impaired in Kap1-deficient B cells.
Impaired AID binding results in reduced levels of DNA 
damage at the S
To determine whether impaired AID recruitment in Kap1-
deficient B cells translates into reduced levels of DNA dam-
age, we measured the mutation frequency in the 5 end of   
S by cloning and sequencing. This assay has been used to assess 
Figure 4.  AID binding to S is impaired by Kap1 deficiency and results in reduced levels of DNA damage. (A) ChIP analysis for AID occupancy at 
the S switch region in CD19Cre/+Kap1F/+, CD19Cre/+Kap1F/F, and AIDCre/Cre B cells cultured in vitro with LPS + IL-4 for 60 h. Normalized AID-ChIP data from 
three experiments assayed with two different primer sets are shown. For each sample, AID-ChIP values were normalized to the input control and subtracted 
from the bead-only negative control. AID-ChIP signal in CD19Cre/+Kap1F/+ B cells was assigned an arbitrary value of 1. P-values were determined by the one-
tailed Student’s t test. Error bars indicate SD. (B and C) Mutation analysis in the 5 end of S in CD19Cre/+Kap1F/F and CD19Cre/+Kap1F/+ LPS + IL-4–stimulated 
B cells (72 h) as determined by Sanger sequencing (B) or HTS (C). Data are from five and four independent experiments, respectively. Background mutation 
frequency was determined on tail genomic DNA. Pie charts in B are as in Fig. 2. P-values were determined by the two-tailed Student’s t test.1654 Epigenetic tethering of AID to the  switch region | Jeevan-Raj et al.
with histone modi-
fications  associated 
with the IgH locus, 
we performed ChIP experiments on resting and activated con-
trol and CD19Cre/+Kap1F/F B cells (Fig. 6 and Figs. S6 and S7). 
Consistent with a previous study (Wang et al., 2009), we 
found that histone H3 associated with the pair of recombin-
ing switch regions is acetylated at lysine 9 and 14 (H3K9/
K14Ac) in B cells undergoing CSR (Fig. 6 A) and that this 
correlated with switch region transcription (Fig. 3 A). Con-
sistent with normal levels of germline transcripts in Kap1-
deficient B cells (Fig. 3 A), we found that H3K9/K14Ac 
was  not  affected  by  Kap1  deficiency  (Fig.  S6). Although 
H3K9me3 has been reported to be induced at the donor and 
acceptor switch regions during CSR (Chowdhury et al., 
2008; Kuang et al., 2009), we found that H3K9me3 was   
already present at the IgH locus before recombination in 
resting B cells (Fig. 6 B). Upon stimulation, the level of 
H3K9me3 was substantially reduced throughout the locus 
but was specifically retained over the donor switch region 
(S; Fig. 6 B and Table S2) when compared with sequences 
located immediately downstream of the variable region (JH4), 
the I exons, the CH exons, or regions surrounding the Mest 
promoter, which were included as positive and negative con-
trols (Riclet et al., 2009). Surprisingly, H3K9me3 retention 
was not observed at S3 when cells were stimulated to switch 
to IgG3 with LPS, nor at S1 when cells were stimulated to 
switch to IgG1 with LPS + IL-4 (Fig. 6 B). The H3K9me3 
pattern was similar in Kap1-deficient B cells (Fig. S6 and 
Table S3), indicating that this modification is not dependent 
on KAP1. Interestingly, we found that KAP1, together with 
coprecipitated AIDFlag-HA  (Fig.  5 A). To  determine  whether 
KAP1, HP1, and AID exist in a complex, we fractionated Flag 
immunoprecipitates by gel filtration chromatography using a   
Superose 6 column and assayed the different fractions for AID, 
KAP1, and HP1 isoforms by Western blot (Fig. 5 B). We found 
that AIDFlag-HA, KAP1, and HP1- coelute in fractions corre-
sponding to a complex of 670 kD (Fig. 5 B). However, the ma-
jority of HP1- was eluted in low molecular weight fractions 
(Fig. 5 B), indicating that only a small fraction of the complex 
contains HP1- or that the in vitro association of HP1- within 
the complex is weaker. HP1- and HP1- were not detected 
(Fig. 5 B). To determine whether the AID–KAP1–HP1 complex 
is able to bind H3K9me3 residues, we performed peptide pull-
down experiments using nuclear extracts from cells expressing 
AIDFlag-HA, EGFPFlag-HA, or AIDFlag-HA 182–198 and biotinylated 
histone H3 peptides either unmodified or trimethylated at lysine 9. 
We found that the H3K9me3 peptide precipitated KAP1, all 
the HP1 isoforms, and AIDFlag-HA (Fig. 5 C). Precipitation of 
AIDFlag-HA was specific, as this peptide did not precipitate   
EGFPFlag-HA (Fig. 5 C). The H3K9me3 peptide also precipitated 
AIDFlag-HA 182–198 (Fig. 5 C), indicating that the C-terminal do-
main of AID is not required for the recognition of H3K9me3 resi-
dues by the AID–KAP1–HP1 complex. We conclude that KAP1, 
HP1, and AID exist in a complex that binds H3K9me3 in vitro. 
Therefore, this modification could serve as a tethering motif for a 
complex formed by AID, KAP1, and HP1 during CSR in vivo.
H3K9me3 and KAP1 mark the donor switch region  
before and during CSR
To determine whether KAP1 and HP1 are recruited to switch 
regions during CSR in vivo and whether this correlates 
Figure 5.  AID forms a complex with 
KAP1 and HP1 that binds H3K9me3.  
(A) Nuclear extracts prepared from CH12 cells 
expressing AIDFlag-HA were immunoprecipitated 
and blotted with anti–HP1-, anti–HP1-, 
anti–HP1-, and anti-Flag antibodies. Data are 
representative of three independent experi-
ments. (B) Flag immunoprecipitates eluted 
with the Flag peptide were fractionated with a 
Superose 6 gel filtration column. The indicated 
fractions were analyzed by Western blot using 
antibodies specific for KAP1, HP1-, HP1-, 
HP1-, and AID. Arrows indicate the elution 
position of calibration proteins of known mo-
lecular mass. Data are representative of two 
independent experiments. (C) Peptide pull-
downs (PPD) using biotinylated unmodified 
(H3) or modified H3 peptides (H3K9me3) and 
avidin-agarose beads (Avidin) on nuclear  
extracts prepared from CH12 cells stably  
expressing AIDFlag-HA, EGFPFlag-HA, or  
AIDFlag-HA 182–198. Precipitated proteins were 
separated by SDS-PAGE and blotted with anti-
bodies specific for KAP1, HP1-, HP1-, HP1-, 
and Flag. Data are representative of three 
independent experiments. (A–C) Molecular 
mass markers in kilodaltons are indicated. IP, 
immunoprecipitation; WB, Western blot.JEM Vol. 208, No. 8 
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Figure 6.  H3K9me3 and KAP1 mark the donor switch region (S) before and during CSR. (A–D) ChIP analysis performed on chromatin prepared 
from resting or LPS-stimulated (48 h) and LPS + IL-4–stimulated (48 h) B cells obtained from CD19Cre/+Kap1F/+ mice using antibodies specific for H3K9/
K14Ac (A), H3K9me3 (B), KAP1 (C), and HP1- (D). Real-time quantitative PCR was performed by using primer pairs specific for JH4, I, S, C, I3, S3, 
C3, I1, S1, and C1. Regions surrounding the Mest promoter (10 kb and 0.5 kb) were used as negative and positive controls, respectively (Riclet  
et al., 2009). Fold change over control IgG is expressed as a percentage of input. Mean (+SD) of triplicate samples is shown. P-values were determined  
by the one-tailed Student’s t test (H3K9me3, LPS: *, P = 0.0003; **, P < 0.0001; ***, P < 0.0001; ****, P < 0.0001; H3K9me3, LPS + IL-4: *, P < 0.0001; **, P = 0.0001; 
***, P = 0.0004; ****, P < 0.0001; KAP1, LPS: *, P = 0.0040; **, P = 0.0065; ***, P = 0.0289; KAP1, LPS + IL-4: *, P = 0.0134; **, P = 0.0170; ***, P = 0.0346).  
See Tables S2 and S5 for detailed statistical analysis and primer sequences, respectively. Data are representative of four independent experiments  
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H3K9me3, is recruited to the IgH locus in resting B cells. 
However, KAP1 binding was predominant over S when 
compared with downstream regions (Fig. 6 C). Upon stim-
ulation,  KAP1  was  released  from  the  locus  but  was   
preferentially retained over S (Fig. 6 C). KAP1 recruitment 
was specific as no significant ChIP signal above background 
was found in Kap1-deficient B cells (not depicted). HP1- 
binding differed from H3K9me3 and KAP1 in that it was 
distributed throughout the locus in resting and activated   
B cells (Fig. 6 D, Fig. S7, and Table S4). Increased HP1- 
binding at C in activated B cells was observed (Fig. 6 D) but 
was not reproducible (Fig. S7). We conclude that H3K9me3, 
HP1-, and KAP1 are present at the IgH locus as part of a 
heterochromatic signature in resting B cells and that H3K9me3 
and KAP1 specifically mark the donor switch region (S) 
before and during CSR.
The in vivo KAP1–HP1 association is required for efficient 
AID binding at S and CSR
To determine whether the in vivo association between KAP1 
and HP1 is required to sustain CSR, we bred CD19Cre/+ 
Kap1F/F mice with knockin mice (Kap1V488A-L490A; Herzog   
et al., 2011) expressing a mutated KAP1 protein that is un-
able to associate with the HP1 proteins (Cammas et al., 2004) 
to  generate  CD19Cre/+Kap1V488A-L490A/F  mice.  Although   
B cells isolated from CD19Cre/+Kap1V488A-L490A/+ mice (express-
ing a wild-type KAP1 and a mutant protein) underwent CSR 
at  wild-type  frequencies  (similar  to  CD19Cre/+Kap1F/+),   
B cells isolated from CD19Cre/+Kap1V488A-L490A/F mice (express-
ing only the KAP1 mutant protein, which cannot associate 
with HP1; Fig. S2) displayed the same CSR defect observed 
in CD19Cre/+Kap1F/F B cells (Fig. 7, A and B). We conclude 
that the in vivo association between KAP1 and HP1 is re-
quired to sustain efficient CSR.
To determine whether AID binding to S is dependent 
on the interaction between KAP1 and HP1, we performed 
AID-ChIP experiments on chromatin prepared from CD19Cre/+ 
Kap1F/+, CD19Cre/+Kap1V488A-L490A/F, and AIDCre/Cre activated 
B cells (Fig. 7 C). We found that AID occupancy at the S 
switch  region  was  significantly  reduced  (P  <  0.0001)   
in CD19Cre/+Kap1V488A-L490A/F when compared with CD19Cre/+ 
Kap1F/+ B cells (Fig. 7 C). The reduction in AID retention at 
S was similar to that observed in Kap1-deficient B cells   
(Fig. 4 A). We conclude that the in vivo association between 
KAP1 and HP1 is required to mediate the efficient binding of 
AID to the donor switch region and to sustain CSR and that 
Figure 7.  The in vivo association between KAP1 and HP1 is  
required for efficient CSR. (A) IgG1 cell surface expression in CD19Cre/+ 
Kap1F/+, CD19Cre/+ Kap1V488A-L490A/+, CD19Cre/+Kap1F/F, and CD19Cre/+ 
Kap1V488A-L490A/F CFSE-labeled B cells stimulated with LPS + IL-4 for 3 d. 
The percentage of switched cells is indicated in each plot. (B) Percentage 
(+SD) of CSR in CD19Cre/+Kap1F/+, CD19Cre/+Kap1F/F, and CD19Cre/+  
Kap1V488A-L490A/F relative to CD19Cre/+Kap1F/+. CSR in CD19Cre/+Kap1F/+ B cells 
was set to 100%. Data are from five independent experiments. P-values were 
determined by the one-tailed Student’s t test (*, CD19Cre/+Kap1F/+ vs. 
CD19Cre/+Kap1F/F: IgG3, P = 0.0154; IgG1, P = 0.0035; IgG2b, P = 0.0264; 
IgG2a, P = 0.001; **, CD19Cre/+Kap1F/+ vs. CD19Cre/+Kap1V488A-L490A/F: IgG3,  
P = 0.0017; IgG1, P = 0.0036; IgG2b, P = 0.0276; IgG2a, P = 0.0004).  
(C) ChIP analysis for AID occupancy at the S switch region in CD19Cre/+ 
Kap1F/+, CD19Cre/+Kap1V488A-L490A/F, and AIDCre/Cre B cells cultured in vitro 
with LPS + IL-4 for 60 h. Normalized AID-ChIP data from three experi-
ments assayed with two different primer sets are shown. For each sample, 
AID-ChIP values were normalized to the input control and subtracted 
from the bead-only negative control. AID-ChIP signal in CD19Cre/+Kap1F/+ 
B cells was assigned an arbitrary value of 1. P-values were determined by 
the one-tailed Student’s t test. Error bars indicate SD.
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pattern of H3K9me3, our results differ from a previous study 
(Kuang et al., 2009) as we find that this modification is not 
inducible. Although it is difficult to pinpoint the reason for 
this discrepancy, it most likely relates to technical issues such 
as differences in culture conditions, time points assayed, de-
tection methods, etc. Nevertheless, the specific enrichment 
of KAP1 binding at S that we observe suggests that H3K9me3 
can serve as a recognition motif for an AID–KAP1–HP1 
complex in vivo at the donor switch region during CSR. Al-
though we cannot provide an explanation as to why KAP1 
recruitment expands up to C or why it is not recruited to 
the acceptor switch regions, this suggests that additional fac-
tors and/or histone modifications may be required to limit 
the range of AID recruitment and/or to modulate the effi-
ciency of its retention. As we did not observe recruitment of 
KAP1 at S3 or S1, it is possible that KAP1 deficiency has 
no impact in the tethering efficiency of AID to acceptor 
switch regions, the efficiency of cytidine deamination, and 
the subsequent generation of DSBs. As DSB formation at ac-
ceptor switch regions has been suggested to be a rate-limiting 
step in CSR (Reina-San-Martin et al., 2003; Schrader et al., 
2003), it might explain why the impairment in CSR in the 
absence of KAP1 is not more profound.
H3K9me3 is usually associated with heterochromatin for-
mation and gene silencing. However, increasing evidence 
suggests additional roles for heterochromatin (Grewal and Jia, 
2007), for example in recruiting factors that facilitate access of 
RNA polymerase II to heterochromatic regions (Zofall and 
Grewal, 2006) or by acting as a recruitment platform for fac-
tors regulating long-range chromosomal interactions (Jia   
et al., 2004). The presence of HP1- throughout the IgH   
locus before and during CSR is reminiscent of the mating-type 
switching in the fission yeast Schizosaccharomyces pombe, in 
which heterochromatin promotes the spreading of the re-
combination-promoting  complex  across  the  mating  locus 
and imposes structural constraints that are important for the 
choice of the recombination donor site (Jia et al., 2004). In-
deed, H3K9me3 has been shown to be present, along with 
HP1-, at actively transcribed genes in mammalian cells (Vakoc 
et al., 2005) and at recombining switch regions in mouse and 
human B cells (Chowdhury et al., 2008; Kuang et al., 2009). 
Strikingly, we demonstrate that the in vivo KAP1–HP1 asso-
ciation is required for efficient AID binding at S and to sus-
tain CSR by expressing a KAP1 mutant that cannot associate 
with HP1 (in a Kap1-deficient background).
Our observations are consistent with a model in which 
AID forms a complex with KAP1 and HP1 that is tethered to 
transcribed switch regions bearing the H3K9me3 mark. There 
is precedent for a model based on the recognition of a modi-
fied histone, as recognition of hypermethylated histone H3 at 
lysine 4 by the PHD domain of RAG2 promotes efficient 
V(D)J recombination (Liu et al., 2007; Matthews et al., 2007). 
In our model, H3K9me3 and associated KAP1 and HP1- 
mark the S region before recombination. Upon stimulation, 
these marks are retained over the S and provide a docking 
motif for AID tethering in vivo. AID would then be retained 
a complex formed by AID, KAP1, and HP1 is tethered to the 
transcribed donor switch region bearing the H3K9me3 mark 
in vivo.
DISCUSSION
We have found that AID forms a complex with KAP1 and 
HP1 and that Kap1 inactivation results in a CSR-specific de-
fect that phenocopies mice deficient for components of the 
DDR (i.e., defective CSR and normal SHM; Ramiro et al., 
2007). Because KAP1 has been reported to be an effector of 
the DDR downstream of ATM (Ziv et al., 2006) and because 
Kap1 inactivation results in a CSR-specific defect similar to 
Atm/ mice (Lumsden et al., 2004; Reina-San-Martin et al., 
2004), we hypothesized that the function of KAP1 in CSR is 
to respond to AID-induced DNA damage. However, we 
found that the role of KAP1 in CSR is independent of its 
phosphorylation status at serine 824 and that its inactivation 
does not result in defective DNA repair or increased genomic 
instability. Therefore, KAP1 does not appear to participate in 
the repair of AID-induced DNA damage during CSR.
Impaired CSR in the absence of KAP1 could be ex-
plained by a global reactivation of genes normally silenced by 
a KAP1-dependent mechanism (Nielsen et al., 1999) or by   
a substantial deregulation of chromatin structure (Ziv et al., 
2006) at the IgH locus. However, this is unlikely as the tran-
scriptional repressor activity of KAP1 requires its association 
with HP1 (Sripathy et al., 2006), and we show that the ex-
pression of a KAP1 mutant protein that cannot associate with 
HP1 (Cammas et al., 2004) was unable to restore CSR to 
wild-type levels. Furthermore, no significant alterations in 
switch region transcription were observed because of Kap1 
deficiency. We believe that the long-range interactions be-
tween switch region promoters and IgH enhancers, which 
are controlled by transcription (Wuerffel et al., 2007), are 
most likely not affected and that the global three-dimensional 
structure of the IgH locus is not altered by Kap1 deficiency. 
The local access of AID to the switch region is most likely 
not affected in the absence of KAP1 because AID targeting to 
switch regions appears to be dependent on its association 
with Spt5 and RNA polymerase II (Pavri et al., 2010) and 
because Kap1 inactivation reduces but does not abolish the 
recruitment of AID to S.
We pinpoint the role of KAP1 in CSR to a step that facili-
tates AID recruitment and the subsequent generation of DNA 
damage at S. We find a substantial reduction in AID recruit-
ment that is in contrast with the 50% reduction in CSR that 
we observe in Kap1-deficient B cells. This might relate to dif-
ferences in the immunoprecipitation efficiency between ex-
periments. As the AID-ChIP signal in Kap1-deficient B cells 
(relative to controls) ranged between 20 and 50% depending 
on the experiment, we think that it might be underestimated.
We show that AID forms a complex with KAP1 and HP1 
that selectively recognizes H3K9me3 in vitro. We also show 
that H3K9me3, KAP1, and HP1 are recruited to the IgH locus 
in resting B cells and that upon activation H3K9me3 and 
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Real-time  quantitative  PCR. RNA and cDNA were prepared using 
standard techniques. Quantitative PCR was performed using SYBR green 
JumpStart  Taq  ReadyMix  (Sigma-Aldrich)  or  QuantiTect  SYBR  green 
PCR kit (QIAGEN). Approximately 3 ng cDNA or 3–5 × 106 cell equiva-
lents of de–cross-linked chromatin were run (in triplicate) and analyzed on a 
LightCycler 480 (Roche). Transcript or DNA quantities were calculated 
relative to standard curves and normalized to CD79b transcripts or input 
DNA. Gene of interest/CD79b or region of interest/input DNA ratios were 
averaged across experiments and normalized to the appropriate controls.
S mutation analysis. The 5 end of S was amplified by PCR using Pfu 
Turbo as described previously (Reina-San-Martin et al., 2004) or using 
Platinum Taq polymerase (Invitrogen) and bar-coded primers (Table S5) for 
HTS. HTS amplification conditions were as follows: 30 cycles of 94°C (15 s), 
60°C (15 s), and 68°C (1 min). PCR products were purified with AmPure 
beads (Agencourt), quantified using Quan-iT Pico Green (Invitrogen), and 
mixed in equimolar ratios before sequencing with a 454 GS FLX sequencer 
(Roche; GATC). Sequences were aligned with Lasergene (DNASTAR) and 
analyzed with SHMTool (Maccarthy et al., 2009).
Peptide pull-downs. Avidin-conjugated agarose beads (Thermo Fisher Sci-
entific) were coupled to biotinylated unmodified or modified H3 peptides   
(A1RTKQTARK9[me3]STGGKAPRKQLATK23-biotin; letters in bold indi-
cate the modified amino acid, and the type of modification is in brackets) for 
3 h at 25°C with rotation, washed in PBS 1× NP-40 0.1% and resuspended 
as a 50% slurry. 5 mg of nuclear extracts was precleared with avidin-agarose 
beads and incubated overnight with peptide-bound resin (40 µl, 50% slurry). 
Resin was washed and resuspended in 20 µl of Laemmli buffer. Proteins were 
fractionated by SDS-PAGE and analyzed by Western blot.
ChIP. The protocol was adapted from Millipore (http://www.millipore.
com/userguides/tech1/mcproto407). In brief, 3 × 107 resting or stimulated 
B cells were cross-linked at 37°C for 10 min in 5 ml PBS/0.5% BSA with 
1% formaldehyde. The reaction was quenched with 0.125 M glycine. After 
lysis, chromatin was sonicated to 0.5–1 kb using a Vibracell 75043 (Thermo 
Fisher Scientific). After 2× dilution in ChIP buffer (0.01% SDS, 1.1% Triton 
X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, and 167 mM NaCl), 
chromatin was precleared by rotating for 2 h at 4°C with 80 µl of 50% pro-
tein A/G slurry (0.2 mg/ml sheared salmon sperm DNA, 0.5 mg/ml BSA, 
and 50% protein A/G; GE Healthcare). 0.3–0.5 × 106 cell equivalents were 
saved as input, and 3–5 × 106 cell equivalents were incubated overnight with 
specific or control antibodies (Table S6). Immune complexes were precipi-
tated by the addition of protein A/G or Dynabeads protein A (for AID) and 
processed according to the Millipore protocol.
Gel filtration chromatography. 20 mg of nuclear extract was immuno-
precipitated with Flag M2–agarose beads in IP-300 buffer, washed, and 
eluted with 0.2 mg/ml Flag peptide in 100 µl. Eluted proteins were fraction-
ated using an micro Superose 6 PC 3.2/30 column (ÄKTA). 100 µl of pro-
teins in each fraction was analyzed by Western blot.
Online supplemental material. Fig. S1 shows Western blot analysis of 
nuclear and cytoplasmic extracts prepared from CH12 cells expressing   
AIDFlag-HA, Western blot analysis of nuclear extracts from CH12 cells expressing 
AIDFlag-HA,  EGFPFlag-HA,  and  AIDFlag-HA  182–198,  SDS-PAGE  (silver  stain) 
analysis of proteins eluted after tandem affinity purification, and the KAP1 
peptides identified by mass spectrometry. Fig. S2 shows that Kap1 deficiency 
has no major impact on B cell development. Fig. S3 displays two additional 
experiments showing that Kap1 deficiency results in reduced levels of post-
recombination transcripts without decreasing germline transcription. Fig. S4 
shows that Kap1 deficiency has no effect on the frequency of germinal center 
B cells and the distribution or pattern of somatic mutations. Fig. S5 shows 
that AID overexpression in Kap1-deficient B cells does not rescue CSR. Fig. S6 
displays two independent experiments showing that Kap1 deficiency does 
not alter the pattern of H3K9me3 or H3K9/K14Ac marks at the IgH locus. 
in close proximity to its substrate by KAP1, HP1, and H3K9me3, 
thus increasing the probability of cytidine deamination, the 
efficiency of DSB formation, and consequently of CSR. Our 
results thus provide a mechanism linking AID to epigenetic 
modifications associated with the IgH locus during CSR.
MATERIALS AND METHODS
Mice. Kap1F/F (Cammas et al., 2000), CD19Cre/+ (provided by K. Rajewsky, 
Harvard Medical School, Boston, MA; Rickert et al., 1997), Kap1V488A-L490A/+ 
(Herzog et al., 2011), and AIDCre/Cre (Robbiani et al., 2008) mice were on a 
C57BL/6 background and were bred and maintained under specific patho-
gen-free conditions. Age-matched littermates (8–12 wk old) were used in all 
experiments. All animal work was performed under protocols approved by 
the Direction des Services Vétérinaires du Bas-Rhin, France (Authorization 
no. 67–343).
Splenic B cell purification, CSR assays, and two-color IgH-FISH. 
Resting splenic B cells were isolated, cultured in vitro with LPS (CSR to 
IgG3 and IgG2b), LPS + IL-4 (CSR to IgG1 and IgE), or LPS + IFN- 
(CSR to IgG2a), and assayed for CSR as described previously (Robert et al., 
2009). Switch transcripts, switch junctions, and IgH/c-myc translocations 
were  analyzed  as  described  previously  (Robert  et  al.,  2009).  Metaphase 
spreads were prepared and subjected to two-color IgH-FISH as described 
previously (Franco et al., 2006).
Nuclear extracts and tandem affinity purification. Nuclear extracts and 
chromatin fractions were prepared from 12 × 109 cells using standard tech-
niques. 20 mg of clarified extracts was taken into immunoprecipitation buffer 
(IP-300: 20 mM Tris, pH 7.9, 300 mM KCl, 20% glycerol, 0.25 mM EDTA, 
0.125 mM EGTA, 0.5 mM PMSF, 1 mM DTT, 0.025% NP-40, 1× protease 
inhibitor cocktail [Roche], and 100 U/ml Benzonase [EMD]) and precleared 
with mouse IgG and protein G–agarose (GE Healthcare) for 1 h at 4°C. Flag 
M2 agarose beads (100 µl, 50% slurry; Sigma-Aldrich) were added and incu-
bated overnight at 4°C. Immune complexes were eluted three times with 100 µl 
of 0.2 mg/ml Flag peptide (30 min at 4°C). Elutions were pooled and 
subjected to immunoprecipitation with anti-HA agarose beads (40 µl, 50% 
slurry; 4 h at 4°C; Roche). Immune complexes were eluted twice with 40 µl 
of 0.1 M glycine, pH 2.4 (10 min), or by overnight incubation with 40 µl of 
0.6 mg/ml HA peptide. Proteins were fractionated by SDS-PAGE in 4–12% 
gradient gels (Invitrogen) and stained with Coomassie blue (G250; Bio-Rad 
Laboratories) before processing for mass spectrometry.
Mass spectrometry analysis. Whole lanes from one-dimensional electro-
phoresis were systematically excised in 5-mm bands. Proteins in bands 
were subjected to in-gel reduction, alkylation, and trypsin digestion. Pep-
tides were dried, resuspended in 0.1% formic acid, and injected into the 
nano liquid chromatography (Ultimate 3000; Dionex) coupled with a lin-
ear ion trap mass spectrometer equipped with a nanoelectrospray source 
(LTQ  XL  ETD; Thermo  Fisher  Scientific). Tandem  mass  spectrometry 
spectra were recorded in the data-dependent mode on the five most intense 
ions observed in mass spectrometry scan with collision-induced dissocia-
tion and electron transfer dissociation fragmentation. Peptides selected for 
tandem mass spectrometry acquisition were then dynamically excluded for 
30 s. Protein ID was performed using Proteome Discoverer 1.1 (Thermo 
Fisher  Scientific)  and  SEQUEST  (Thermo  Fisher  Scientific)  searching 
against the mouse Swiss-Prot database (version 57.9) with the following 
fixed parameters: precursor mass tolerance of ±0.5 D, product ion mass tol-
erance of ±0.8 D, and two missed cleavages, and carbamidomethylation of 
cysteine as fixed modification and methionine oxidation as variable modi-
fication. SEQUEST results were filtered with Xcorr versus charge state 
1.5-1, 1.6-2, 3-3, 3.2-4.
SHM analysis. Germinal center B cells (B220+Fas+GL-7+) were sorted from 
the lymph nodes of NP-CGG–immunized mice and analyzed for mutation in 
JH4 intron sequences (Jolly et al., 1997) with SHMTool (Maccarthy et al., 2009).JEM Vol. 208, No. 8 
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